Concomitant use of insulin glargine and NPH in type I diabetes

Indian Pediatrics

Volumn 42, Issue 8, 2005, Pages 796-800

  Khadilkar, Vaman V ^a   Khadilkar, A V ^a  

^a JEHANGIR HOSPITAL   (India)

Author keywords

Glycosylated hemoglobin; Insulin glargine; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; ISOPHANE INSULIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

ADOLESCENT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN, NPH; MALE; PROSPECTIVE STUDIES;

EID: 23944461486     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Owens DR, Griffiths S. Insulin glargine (Lantus). Int J Clin Pract 2002, 56: 460-466.
2. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 2000, 23: 639-643.
3. Pieber TR, Eugene-Jolchine I, Derobert E. The European Study Group of HOE 901 in type 1 diabetes. Efficacy and safety of HOE Diabetes Care 2000, 23: 157-162.
4. Virmani A, Bhatia V. Ambulatory Management of Diabetes Mellitus. In: Desai MP, Bhatia V, Menon PSN. Pediatric Endocrine Disorders, 1st edn. Chennai, Orient Longman, 2001; p 312-319.
5. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329: 977-986.
6. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000, 49: 2142-2148.